English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/59810
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

DC FieldValueLanguage
dc.contributor.authorSancho, Juan Manuel-
dc.contributor.authorOrfao, Alberto-
dc.contributor.authorQuijano, Sandra-
dc.contributor.authorCaballero, Maria Dolores-
dc.identifierdoi: 10.1111/j.1600-0609.2010.01478.x-
dc.identifierissn: 0902-4441-
dc.identifiere-issn: 1600-0609-
dc.identifier.citationEuropean Journal of Haematology 85(4): 321-328 (2010)-
dc.description.abstract[Background and aim]: Flow cytometry (FCM) analysis of cerebrospinal fluid (CSF) is more sensitive than conventional cytology (CC) for diagnosis of lymphomatous meningeosis, but the clinical significance of occult central nervous system (CNS) disease (positive FCM with negative CC) remains unknown. [Patients and methods]: CSF samples from 105 patients with newly diagnosed aggressive lymphomas at high risk of CNS involvement were prospectively studied by both CC and FCM, and results were correlated with cumulative incidence of CNS relapse and overall survival (OS). Patients were divided into three groups: 1) patients without CNS involvement (CC−/FCM−; n = 83); 2) individuals with occult CNS disease (FCM+/CC−; n = 15); and 3) cases with CNS disease (CC+/FCM+; n = 7). [Results]: Six cases showed CNS relapse or progression: two in Group 1 (2.4%), two in Group 2 (13%) and two in Group 3 (28.5%) (Group 2 vs. 1, P = 0.04; Group 3 vs. 1, P < 0.001). Patients from Groups 2 (P = 0.05) and 3 (P < 0.001) also showed a higher cumulative incidence of CNS relapse than those from Group 1. Significant differences were observed in OS between FCM−/CC− and FCM+/CC+ cases (P = 0.02), while patients with occult CNS disease (FCM+/CC−) displayed intermediate OS rates, although differences did not reach statistical significance. [Conclusions]: The presence of occult CNS involvement at diagnosis in patients with NHL at high risk of CNS disease is associated with a higher probability of CNS relapse.-
dc.description.sponsorshipThis work was supported in part by grants P-EF ⁄ 08 from Jose Carreras International Leukemia Foundation, RD 06 ⁄ 0020 ⁄ 1056 from RETICS and an unrestricted grant from Mundipharma Pharmaceuticals, SL.-
dc.publisherJohn Wiley & Sons-
dc.titleClinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non-Hodgkin's lymphoma patients at high risk of central nervous system disease in the rituximab era-
dc.description.versionPeer Reviewed-
Appears in Collections:(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show simple item record

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.